Financing and Investment Products

Corporate / M&A

IP / IT

Competition

Regulatory

Employment and Executive Compensation

On July 13, 2023, Homburger received the «Impact Deal of the Year» award at the LMG Life Sciences Awards EMEA 2023 for its work on <a href="https://www.homburger.ch/en/news/homburger-advises-csl-with-respect-to-its-announced-public-tender-offer-to-acquire-vifor-pharma">CSL/Vifor</a>. Our team was led by partners Dieter Gericke and Daniel Häusermann. It also included members from our Tax, Financing and Investment Products, Competition and Regulatory, IP / IT, Corporate/M&amp;A, and Employment and Executive Compensation teams.
The awards aim to recognize complex and impactful work across an array of legal specialisms that operate within the life sciences industry.

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Capital Markets

Meyer Burger

Homburger News

Share-Image Teamplate Deals-and-Cases

On May 17, 2023, Meyer Burger Technology AG (SIX: MBTN) (Meyer Burger) successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The bonds are issued by Meyer Burger&#8217;s subsidiary MBT Systems GmbH and guaranteed by Meyer Burger.
With the net proceeds from the issue of the bonds, Meyer Burger primarily intends to finance and/or refinance investments in Eligible Green Projects as defined by Meyer Burger’s Green Financing Framework, including material and equipment sourcing and the ramp up of module and cell production in response to the expected acceleration of solar energy expansion.
Homburger AG acted as legal counsel to Meyer Burger on this transaction. The Homburger team was led by Dieter Gericke (Corporate / M&amp;A, Capital Markets) and Benjamin Leisinger (Capital Markets) and included Stefan Oesterhelt (Tax), Eduard De Zordi and Daniel Hulmann (both Capital Markets) and Estelle Piccard (Corporate / M&amp;A, Capital Markets).

Homburger advised Meyer Burger Technology AG on the issuance of green senior unsecured guaranteed convertible bonds due 2029 in the amount of EUR 216.3 m

ADC Therapeutics

On February 2, 2023, ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced the pricing of an underwritten offering of 12 m ADCT shares owned by an affiliate of Auven Therapeutics, at a price of USD 5.00 per share. ADCT itself did not sell any shares in the offering.
The Homburger team was led by Daniel Häusermann (Corporate / M&amp;A, Capital Markets) and included Estelle Piccard (Corporate / M&amp;A, Capital Markets).

Homburger advised ADC Therapeutics SA on the Underwritten Offering by a Selling Shareholder

Estelle
Piccard

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Homburger advised Meyer Burger Technology AG on the issuance of green senior unsecured guaranteed convertible bonds due 2029 in the amount of EUR 216.3 m

Homburger advised ADC Therapeutics SA on the Underwritten Offering by a Selling Shareholder

Join the Team

Estelle Piccard

Career

Languages

Bar Registration

Teams

EstellePiccard

Homburger honored with LMG Life Sciences EMEA award for «Impact Deal of the Year»

Homburger advised Meyer Burger Technology AG on the issuance of green senior unsecured guaranteed convertible bonds due 2029 in the amount of EUR 216.3 m

Homburger advised ADC Therapeutics SA on the Underwritten Offering by a Selling Shareholder

Join the Team

Estelle Piccard

Career

Languages

Bar Registration

Teams

Estelle
Piccard